+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Needle-Free Drug Injection Systems - Global Strategic Business Report

  • PDF Icon

    Report

  • 278 Pages
  • February 2025
  • Region: Global
  • Global Industry Analysts, Inc
  • ID: 5968956
The global market for Needle-Free Drug Injection Systems was valued at US$17.3 Billion in 2024 and is projected to reach US$29.9 Billion by 2030, growing at a CAGR of 9.5% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.

Needle-Free Drug Injection Systems - Key Trends and Drivers

The growth of the needle-free drug injection system market is driven by multiple factors, including continuous technological innovations that enhance drug delivery mechanisms and device ergonomics. These advancements make the systems more efficient and user-friendly, fostering broader adoption. Stricter regulatory and safety standards aimed at reducing needlestick injuries and related liabilities also promote the shift towards needle-free systems. Healthcare worker advocacy and patient demand for less invasive treatment options further influence this trend, especially among individuals with needle aversions. Additionally, the integration of these systems with digital health records facilitates better patient data management, enhancing workflow efficiency. Needle-free systems are particularly cost-effective for mass immunization programs, providing quick and easy vaccine administration. Lastly, these systems align with environmental sustainability goals by reducing medical waste associated with disposable needles, highlighting their appeal in modern healthcare settings where technological efficiency, patient comfort, and environmental considerations are increasingly prioritized.

The implementation of needle-free injection technology addresses several significant safety concerns associated with conventional syringes. By eliminating the risk of needle breaks, these systems enhance food safety and protect consumer health, crucial for maintaining the integrity and marketability of meat products, especially in export markets. Furthermore, needle-free injections reduce the risk of cross-contamination between animals, a common issue with needle injections that can lead to the spread of diseases such as porcine reproductive and respiratory syndrome (PRRS). The design features of these systems also prioritize user safety by minimizing accidental self-injection and repetitive motion injuries among farm workers, contributing to a safer and more ergonomic work environment. However, the transition to needle-free technology requires careful consideration of the direct and indirect costs, including the initial investment and ongoing maintenance of the devices, which may be offset by long-term benefits such as reduced disease transmission and medication costs in larger operations.

Needle-free drug injection systems represent a significant innovation in the realm of animal healthcare, particularly within the swine industry, offering a viable alternative to traditional needle-based injections. This technology enhances animal health outcomes, reduces operational costs, and improves the overall safety of meat production. Needle-free systems administer medications or vaccines by creating a high-pressure jet stream capable of penetrating animal tissue, delivering substances directly into intradermal, subcutaneous, or intramuscular layers. This method not only ensures precise dosage and depth of administration but also adapts to various animal sizes, making it suitable from piglets to full-grown boars and sows. The effectiveness of these systems in eliciting robust immune responses, often superior to traditional methods, underscores their potential to revolutionize standard vaccination protocols and therapeutic treatments in animal husbandry.

Report Scope

The report analyzes the Needle-Free Drug Injection Systems market, presented in terms of market value (USD). The analysis covers the key segments and geographic regions outlined below.

Segments

Technology (Jet Injectors, Novel Needle-Free, Inhaler, Transdermal Patch); Application (Insulin Delivery, Pain Management, Vaccine Delivery, Pediatric Injections, Other Applications).

Geographic Regions/Countries

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Key Insights:

  • Market Growth: Understand the significant growth trajectory of the Jet Injectors Technology segment, which is expected to reach US$9.5 Billion by 2030 with a CAGR of a 9.6%. The Novel Needle-Free Technology segment is also set to grow at 8.6% CAGR over the analysis period.
  • Regional Analysis: Gain insights into the U.S. market, valued at $4.5 Billion in 2024, and China, forecasted to grow at an impressive 12.6% CAGR to reach $6.7 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.

Why You Should Buy This Report:

  • Detailed Market Analysis: Access a thorough analysis of the Global Needle-Free Drug Injection Systems Market, covering all major geographic regions and market segments.
  • Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
  • Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Needle-Free Drug Injection Systems Market.
  • Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.

Key Questions Answered:

  • How is the Global Needle-Free Drug Injection Systems Market expected to evolve by 2030?
  • What are the main drivers and restraints affecting the market?
  • Which market segments will grow the most over the forecast period?
  • How will market shares for different regions and segments change by 2030?
  • Who are the leading players in the market, and what are their prospects?

Report Features:

  • Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
  • In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
  • Company Profiles: Coverage of players such as AKRA Dermojet, Crossject SA, D`Antonio Consultants International, Inc., Medical International Technologies, Inc., National Medical Products, Inc. and more.
  • Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.

Some of the 52 companies featured in this Needle-Free Drug Injection Systems market report include:

  • AKRA Dermojet
  • Crossject SA
  • D`Antonio Consultants International, Inc.
  • Medical International Technologies, Inc.
  • National Medical Products, Inc.
  • PharmaJet
  • Zogenix, Inc.

Table of Contents

I. METHODOLOGYII. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
  • Influencer Market Insights
  • Global Economic Update
  • Needle-Free Drug Injection Systems - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
  • Rising Prevalence of Chronic Diseases Throws the Spotlight on Needle-Free Drug Injection Systems
  • Growing Focus on Pain-Free Delivery Methods Spurs Growth
  • Advancements in Biologics Propel Growth in Needle-Free Drug Delivery
  • Increased Adoption of Home Healthcare Solutions Expands Addressable Market Opportunity
  • Innovations in Jet Injection Technology Strengthen Business Case for Needle-Free Systems
  • Growing Awareness of Needle Stick Injuries and Infections Sustains Growth
  • Here’s the Story on the Transition from Conventional to Needle-Free Systems
  • Here’s How New Formulations and Drugs Accelerate Demand for Needle-Free Technologies
  • Cost-Effectiveness and Efficiency of Needle-Free Systems Propel Market Expansion
  • Rising Use of Self-Administration Techniques Spurs Growth of Needle-Free Devices
  • Technological Advancements and Integration with Smart Technologies Drive Adoption
  • Expansion of Vaccination Programs Generates Demand for Needle-Free Solutions
  • Focus on Reducing Medical Waste Expands Market for Needle-Free Drug Delivery
  • Here’s How Digital Health Trends Drive Adoption of Needle-Free Systems
  • Patient-Centric Approaches Propel Growth in Needle-Free Drug Delivery Market
  • Stringent Regulations on Conventional Needles Propel Shift to Needle-Free Technologies
  • Increasing Geriatric Population Spurs Growth in Needle-Free Drug Injection Systems
  • Here’s the Story on the Evolution of Needle-Free Technology and its Market Impact
4. GLOBAL MARKET PERSPECTIVE
  • Table 1: World Needle-Free Drug Injection Systems Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
  • Table 2: World Recent Past, Current & Future Analysis for Needle-Free Drug Injection Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 3: World Historic Review for Needle-Free Drug Injection Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 4: World 15-Year Perspective for Needle-Free Drug Injection Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • Table 5: World Recent Past, Current & Future Analysis for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 6: World Historic Review for Jet Injectors by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 7: World 15-Year Perspective for Jet Injectors by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 8: World Recent Past, Current & Future Analysis for Novel Needle-Free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 9: World Historic Review for Novel Needle-Free by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 10: World 15-Year Perspective for Novel Needle-Free by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 11: World Recent Past, Current & Future Analysis for Inhaler by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 12: World Historic Review for Inhaler by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 13: World 15-Year Perspective for Inhaler by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 14: World Recent Past, Current & Future Analysis for Transdermal Patch by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 15: World Historic Review for Transdermal Patch by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 16: World 15-Year Perspective for Transdermal Patch by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 17: World Recent Past, Current & Future Analysis for Insulin Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 18: World Historic Review for Insulin Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 19: World 15-Year Perspective for Insulin Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 20: World Recent Past, Current & Future Analysis for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 21: World Historic Review for Pain Management by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 22: World 15-Year Perspective for Pain Management by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 23: World Recent Past, Current & Future Analysis for Vaccine Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 24: World Historic Review for Vaccine Delivery by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 25: World 15-Year Perspective for Vaccine Delivery by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 26: World Recent Past, Current & Future Analysis for Pediatric Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 27: World Historic Review for Pediatric Injections by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 28: World 15-Year Perspective for Pediatric Injections by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • Table 29: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
  • Table 30: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
  • Table 31: World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
  • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
CANADA
JAPAN
  • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
CHINA
  • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
EUROPE
  • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
FRANCE
  • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
GERMANY
  • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
ITALY
UNITED KINGDOM
  • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
SPAINRUSSIAREST OF EUROPE
ASIA-PACIFIC
  • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
AUSTRALIA
  • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
INDIA
  • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
SOUTH KOREAREST OF ASIA-PACIFIC
LATIN AMERICA
  • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
ARGENTINABRAZILMEXICOREST OF LATIN AMERICA
MIDDLE EAST
  • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
IRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EAST
AFRICA
  • Needle-Free Drug Injection Systems Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
IV. COMPETITION

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • AKRA Dermojet
  • Crossject SA
  • D`Antonio Consultants International, Inc.
  • Medical International Technologies, Inc.
  • National Medical Products, Inc.
  • PharmaJet
  • Zogenix, Inc.

Table Information